Impact Factor:3.5

DOI number:10.1016/j.jphs.2019.09.003

Journal:JOURNAL OF PHARMACOLOGICAL SCIENCES

Co-author:Liu, K (Liu, Kun), LY (Zhou, Ling-yun), Li, DY (Li, Dai-yang), Cheng, WJ (Cheng, Wen-jing), Yin, WJ (Yin, Wen-jun), Hu, C (Hu, Can), Xie, YL (Xie, Yue-liang), Wang, JL (Wang, Jiang-lin), Zuo, SR (Zuo, Shan-ru), Chen, LH (Chen, Lin-hua), Zhou, G (Zhou, Ge)

Translation or Not:no

Pre One:Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers Next One:New equation to estimate glomerular filtration rate in China: a reference issue reply